2018 Farm Bill Legalizes Hemp throughout the United States
The new Farm Bill was an early Christmas present for the hemp industry when it was signed by the president just before the December recess. For hemp supporters and the industry it's a cause for celebration. With a few notable exceptions, hemp is now closer to being treated like any other agriculture crop.
Spearheaded by Sen. Mitch McConnell (R-KY) the hemp legalization came after decades of advocacy supporters nationwide. (Read more.)
CBD Oil and Products Gaining in Popularity
CBD Oil is a rising star. Cannabidiol (CBD) is increasingly being used for a variety of conditions including anxiety, insomnia, depression and seizures. People with arthritis, MS and lupus are turning to products like CBD-infused lotion to help manage pain. CBD sales are expected to quadruple in the next four years, from an estimated $535 million in 2018 to more than $1.9 billion by 2022.
A new study on CBD use shows that the most common reasons sought out CBD was for insomnia, depression, anxiety and joint pain. The industry is estimated to have doubled in the last two years. Enthusiasm has outpaced the science, however. (Read more.)
Top Ten Tips for Buying Hemp-Derived CBD Products
When it comes to buying hemp products, consumers are often confused by the range of products and seemingly conflicting information. Here's a list that might help:
Choose CBD products made with American-grown hemp. Learn the difference between full-spectrum, broad spectrum and isolates before making a decision. Beware of companies making explicit health claims. Understand the difference between hempseed products and CBD products. Don't be afraid to ask questions about the products. Reputable companies provide test results and are eager to discuss their products.
Project CBD, the go-to informational website, provides a wealth of information on selecting quality products. (Read more.)
WHO Reviews the Efficacy of CBD
The World Health Organization says that CBD "exhibits no effective indicative of any abuse or dependence potential." In a report filed last fall, the WHO details how CBD has already shown effectiveness in combatting the symptoms of epilepsy in several clinical trials. The decision is important because based on the report's findings, the WHO makes recommendations to countries around the world regarding which substances should be controlled or surveilled.
DEA Chief Wrong about Cannabis
The nation's top drug enforcement officer is opposed to legalizing cannabis--but does he have to be so ill-informed? DEA Chief Robert Patterson said cannabis is a Schedule 1 drug "because of the science" but was unable to cite any studies. Nor had he heard that the Journal of the AMA reported "evidence that cannabis effectively treats chronic pain." He also wrongly believes cannabis contributes to the nation's opioid epidemic, while experts believe it is a solution.
Congress urges VA to Research Cannabis
Despite protestations from the Department of Veterans Affairs to acknowledge medical cannabis as therapy, In addition to encouraging research a new bipartisan bill will give the Veterans Administration permission to allow veterans access to medical cannabis for the treatment of PTSD and chronic pain. Rep. Lou Correa (D-CA), observed, "Rather than risk becoming dependent on opioids, these veterans find relief in medical cannabis." The new bill will push the VA to research cannabis, at last.